When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Cyclooxygenase-2 inhibitor - Wikipedia

    en.wikipedia.org/wiki/Cyclooxygenase-2_inhibitor

    Sales and marketing efforts were supported by two large trials, the Celecoxib Long-term Arthritis Safety Study [44] (CLASS) in JAMA, and the Vioxx Gastrointestinal Outcomes Research (VIGOR). [45] The VIGOR trial was later proven to have been based on faulty data, and Vioxx was eventually withdrawn from the market. [46]

  3. Rofecoxib - Wikipedia

    en.wikipedia.org/wiki/Rofecoxib

    The therapeutic recommended dosages were 12.5, 25, and 50 mg with an approximate bioavailability of 93%. [12] [13] [14] Rofecoxib crossed the placenta and blood–brain barrier, [12] [13] [15] and took 1–3 hours to reach peak plasma concentration with an effective half-life (based on steady-state levels) around 17 hours.

  4. List of withdrawn drugs - Wikipedia

    en.wikipedia.org/wiki/List_of_withdrawn_drugs

    Voluntarily withdrawn from US market because of risk of Progressive multifocal leukoencephalopathy (PML). Returned to market July 2006. Nefazodone: 2004 Europe, Australia, New Zealand and Canada [35] [36] [37] Branded version withdrawn by originator in several countries in 2007 for hepatotoxicity. Generic versions available. Still available in ...

  5. Puzzle solutions for Wednesday, Oct. 23, 2024

    www.aol.com/puzzle-solutions-wednesday-oct-23...

    Daily Commuter crossword SUDOKU. Play the USA TODAY Sudoku Game. JUMBLE. Jumbles: AROSE TWICE WIZARD WHIMSY. Answer: If you can say "absent gone, removed, elsewhere, etc.", you have −"AWAY" WITH ...

  6. Valdecoxib - Wikipedia

    en.wikipedia.org/wiki/Valdecoxib

    On April 7, 2005, Pfizer withdrew Bextra from the U.S. market on recommendation by the FDA, citing an increased risk of heart attack and stroke and also the risk of a serious, sometimes fatal, skin reaction. This was a result of recent attention to prescription NSAIDs, such as Merck's Vioxx.

  7. Pfizer's Oxbryta exit may hasten trials of rival experimental ...

    www.aol.com/news/pfizers-oxbryta-exit-may-hasten...

    Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed up trials of new experimental rivals, Wall Street analysts said. Oxbryta ...

  8. Merck & Co. - Wikipedia

    en.wikipedia.org/wiki/Merck_&_Co.

    On September 28, 2004, Merck notified the FDA that it was voluntarily withdrawing Vioxx from the market, and it publicly announced the withdrawal on September 30. An analysis for the period 1999–2004, based on U.S. Medical Expenditure Survey data, reported that Vioxx was associated with 46,783 heart attacks, and along with the other popular ...

  9. Nicole Kidman Reveals She Owns the Original Handwritten ...

    www.aol.com/nicole-kidman-reveals-she-owns...

    Nicole Kidman is opening up about a treasured memento.. On Thursday, Jan. 30, the actress, 57, appeared on The Late Show with Stephen Colbert and revealed that she bought Bernie Taupin's original ...